AVBP

AVBP Operating Expenses

$175.94MTTM · USD

Period ending:

AVBP FY Operating ExpensesUSD
AVBP FY Operating Expenses2021-12-31: $8.70M2022-12-31: $36.91M2023-12-31: $74.59M2024-12-31: $94.31M2025-12-31: $177.53M$177.53M$0.00
2021-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

AVBP operating expenses history

Expenses from normal business operations (SG&A, R&D, etc.). The available annual fiscal periods series contains 5 observations from Dec 31, 2021 to Dec 31, 2025.

Arrivent Biopharma Inc Operating Expenses — Annual fiscal periods (USD)
Period endingOperating Expenses (USD)
177,534,000
94,308,000
74,590,000
36,906,000
8,696,000

Compare operating expenses

All AVBP financial metrics · AVBP stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.